Christopher Elnan Kvistad

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 458 citations

Thrombosis, Endpoint Trial, Tenecteplase Versus Alteplase +13

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 191 citations

Thrombosis, Tenecteplase Versus Alteplase, Cardiovascular Disease +15

Recurrent ischemic stroke: Incidence, predictors, and impact on mortality

Andrej Netland Khanevski, Anna Therese Bjerkreim, Vojtěch Novotný et al. · Acta Neurologica Scandinavica · 2019 · 168 citations · Full text

When to Screen Ischaemic Stroke Patients for Cancer

Henriette Aurora Selvik, Anna Therese Bjerkreim, Lars Thomassen et al. · Cerebrovascular Diseases · 2018 · 72 citations

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

Nicola Logallo, Christopher Elnan Kvistad, Aliona Nacu et al. · BMC Neurology · 2014 · 57 citations · Full text